• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未经治疗的转甲状腺素蛋白淀粉样心肌病患者及其照料者疾病负担的预测因素:一项国际调查分析

Predictors of disease burden in patients with untreated transthyretin amyloid cardiomyopathy and their caregivers: a analysis of an international survey.

作者信息

Cappelli Francesco, Ponti Lucia, Hsu Kristen, Damy Thibaud, Villacorta Eduardo, Verheyen Nicolas, Keohane Denis, Wang Ronnie, Ines Monica, Kumar Nisith, Munteanu Carmen

机构信息

Tuscan Regional Amyloidosis Referral Centre, Careggi University Hospital, Florence, Italy.

University of Urbino, Urbino, Italy.

出版信息

Front Cardiovasc Med. 2025 Jun 9;12:1595797. doi: 10.3389/fcvm.2025.1595797. eCollection 2025.

DOI:10.3389/fcvm.2025.1595797
PMID:40552190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12183217/
Abstract

INTRODUCTION

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive condition with debilitating symptoms. The self-reported burden of ATTR-CM on patients and their caregivers was previously evaluated in an international, multicenter, real-world survey study.

METHODS

This analysis used univariate and multivariate models to evaluate survey items as predictors of ATTR-CM burden. The final multivariate models were optimized using forward selection and CV Press criteria with 8-fold cross-validation to include only the best predictors. Hierarchical linear regression analyses were used to explore potential moderators of the relationship between patient health status and caregiver burden.

RESULTS

The original survey included 208 patients with ATTR-CM, naïve to disease-modifying treatment, and their unpaid primary caregivers from international amyloidosis centers of excellence in 7 countries between July 2021 and August 2022. Most patients were male (86%), elderly (median age, 81 years), and had untreated wild-type ATTR-CM (91% of 155 with genetic testing). Patients reported fair to good health status overall [Kansas City Cardiomyopathy Questionnaire Overall Summary (KCCQ-OS) median score, 68]. Most (60%) of the 199 patients with a New York Heart Association (NYHA) classification were class II (18% class I; 22% class III). Optimized multivariate models for several measures found symptomatic heart failure (NYHA class II or III), having "weakness, especially in the legs," older age, and female sex, were independent predictors of higher patient-reported burden. The majority of caregivers were female (85%) and the spouse (59%) or adult child (37%) of the patient. The median duration of caregiving was 1.5 years. In the final optimized multivariate model, only the patient's KCCQ-OS score was a significant predictor of caregiver burden. This relationship was not clinically moderated by other patient or caregiver variables.

CONCLUSIONS

Our analysis showed that heart failure symptoms, weakness, especially in the legs, older age, and female sex, are independent predictors of higher disease burden in patients with ATTR-CM. A higher caregiver burden was best predicted by poorer health status in the patient, even in the presence of potential moderators. Implementing strategies to reduce the physical symptoms experienced by patients with ATTR-CM may help to reduce their burden, and that experienced by caregivers.

摘要

引言

转甲状腺素蛋白淀粉样变心肌病(ATTR-CM)是一种症状逐渐加重的疾病。此前,在一项国际多中心真实世界调查研究中评估了ATTR-CM对患者及其照护者的自我报告负担。

方法

本分析使用单变量和多变量模型来评估调查项目,作为ATTR-CM负担的预测因素。最终的多变量模型使用向前选择和CV Press标准以及8折交叉验证进行优化,以仅纳入最佳预测因素。使用分层线性回归分析来探索患者健康状况与照护者负担之间关系的潜在调节因素。

结果

原始调查纳入了208例未接受疾病修饰治疗的ATTR-CM患者及其 unpaid 主要照护者,这些患者来自2021年7月至2022年8月期间7个国家的国际淀粉样变性卓越中心。大多数患者为男性(86%),年龄较大(中位年龄81岁),且患有未经治疗的野生型ATTR-CM(155例接受基因检测的患者中91%)。患者总体报告健康状况为中等至良好[堪萨斯城心肌病问卷总体总结(KCCQ-OS)中位得分68]。199例纽约心脏协会(NYHA)分级患者中,大多数(60%)为II级(I级18%;III级22%)。针对多项指标的优化多变量模型发现,有症状的心力衰竭(NYHA II级或III级)、“虚弱,尤其是腿部”、年龄较大和女性是患者报告的较高负担的独立预测因素。大多数照护者为女性(85%),是患者的配偶(59%)或成年子女(37%)。中位照护时长为1.5年。在最终优化的多变量模型中,只有患者的KCCQ-OS得分是照护者负担的显著预测因素。这种关系未受到其他患者或照护者变量的临床调节。

结论

我们的分析表明,心力衰竭症状、虚弱,尤其是腿部、年龄较大和女性是ATTR-CM患者疾病负担较高的独立预测因素。即使存在潜在调节因素,患者健康状况较差也最能预测照护者负担较高。实施策略减轻ATTR-CM患者经历的身体症状可能有助于减轻他们及其照护者的负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8649/12183217/bb6ff55386bb/fcvm-12-1595797-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8649/12183217/4182c0058c0a/fcvm-12-1595797-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8649/12183217/d75cab7ab680/fcvm-12-1595797-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8649/12183217/bb6ff55386bb/fcvm-12-1595797-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8649/12183217/4182c0058c0a/fcvm-12-1595797-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8649/12183217/d75cab7ab680/fcvm-12-1595797-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8649/12183217/bb6ff55386bb/fcvm-12-1595797-g003.jpg

相似文献

1
Predictors of disease burden in patients with untreated transthyretin amyloid cardiomyopathy and their caregivers: a analysis of an international survey.未经治疗的转甲状腺素蛋白淀粉样心肌病患者及其照料者疾病负担的预测因素:一项国际调查分析
Front Cardiovasc Med. 2025 Jun 9;12:1595797. doi: 10.3389/fcvm.2025.1595797. eCollection 2025.
2
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
5
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.

本文引用的文献

1
Health-related quality of life is an independent predictor of mortality and hospitalisations in transthyretin amyloid cardiomyopathy: a prospective cohort study.健康相关生活质量是转甲状腺素淀粉样变心肌病患者死亡率和住院率的独立预测因素:一项前瞻性队列研究。
Qual Life Res. 2024 Oct;33(10):2743-2753. doi: 10.1007/s11136-024-03723-y. Epub 2024 Aug 6.
2
Burden of untreated transthyretin amyloid cardiomyopathy on patients and their caregivers by disease severity: results from a multicenter, non-interventional, real-world study.按疾病严重程度划分未治疗的转甲状腺素蛋白淀粉样心肌病对患者及其照护者的负担:一项多中心、非干预性、真实世界研究的结果
Front Cardiovasc Med. 2023 Aug 29;10:1238843. doi: 10.3389/fcvm.2023.1238843. eCollection 2023.
3
Health-related quality of life among transthyretin amyloid cardiomyopathy patients.
转甲状腺素蛋白淀粉样变心肌病患者的健康相关生活质量。
ESC Heart Fail. 2023 Jun;10(3):1871-1882. doi: 10.1002/ehf2.14350. Epub 2023 Mar 22.
4
A survey exploring caregiver burden and health-related quality of life in hereditary transthyretin amyloidosis.一项调查探索遗传性转甲状腺素淀粉样变性症患者照料者负担和健康相关生活质量。
Orphanet J Rare Dis. 2023 Jan 26;18(1):17. doi: 10.1186/s13023-022-02601-5.
5
Anxious/Depressive Symptoms Alter the Subjective Perception of Heart Failure Severity in Transthyretin Cardiac Amyloidosis.焦虑/抑郁症状改变了转甲状腺素蛋白心脏淀粉样变性中心力衰竭严重程度的主观认知。
Am J Cardiol. 2023 Apr 1;192:1-6. doi: 10.1016/j.amjcard.2023.01.007. Epub 2023 Jan 21.
6
Minimally Clinically Important Difference in Health Status Scores in Patients With HFrEF vs HFpEF.HFrEF 与 HFpEF 患者健康状况评分的最小临床重要差异。
JACC Heart Fail. 2022 Sep;10(9):651-661. doi: 10.1016/j.jchf.2022.03.003. Epub 2022 Jun 8.
7
Amyloidosis from the patient perspective: the French daily impact of amyloidosis study.从患者角度看淀粉样变性:法国淀粉样变性日常影响研究。
Amyloid. 2022 Sep;29(3):165-174. doi: 10.1080/13506129.2022.2035354. Epub 2022 Feb 11.
8
Health status measured by Kansas City Cardiomyopathy Questionnaire-12 in primary prevention implantable cardioverter defibrillator patients with heart failure.心力衰竭的一级预防植入型心律转复除颤器患者应用堪萨斯城心肌病问卷 12 版评估健康状况。
BMC Cardiovasc Disord. 2021 Aug 28;21(1):411. doi: 10.1186/s12872-021-02218-9.
9
Burden and Quality of Life Among Female and Male Patients with Heart Failure in Europe: A Real-World Cross-Sectional Study.欧洲心力衰竭男女患者的负担与生活质量:一项真实世界横断面研究
Patient Prefer Adherence. 2021 Jul 30;15:1693-1706. doi: 10.2147/PPA.S312200. eCollection 2021.
10
Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy.关于转甲状腺素蛋白淀粉样心肌病监测的专家共识。
Eur J Heart Fail. 2021 Jun;23(6):895-905. doi: 10.1002/ejhf.2198. Epub 2021 May 24.